Kris Coleman (Ohio State University): Publications

More details

Ohio State University

Graduate student

Columbus, Ohio, United States of America

Areas of Interest

Applied Ethics

Meta-Ethics

Normative Ethics

Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome (review)
with E. E. Mlynarski, M. B. Sheridan, M. Xie, T. Guo, S. E. Racedo, D. M. M. McDonald-McGinn, X. Gai, E. W. C. Chow, J. A. S. Vorstman, A. Swillen, K. K. Devriendt, J. Breckpot, M. C. R. Digilio, B. Marino, B. Dallapiccola, Philip N., T. J. Simon, A. E. Roberts, M. Piotrowicz, C. E. Bearden, S. Eliez, D. Gothelf, W. R. Kates, M. Devoto, E. H. Zackai, D. Heine-Suñer, T. H. Shaikh, A. S. Bassett, E. Goldmuntz, B. E. Morrow, and B. S. Emanuel

© 2015 The American Society of Human Genetics. The 22q11.2 deletion syndrome is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect, mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants outside the 22q11.2 deleted region might increase the risk of being born with a…Read more
© 2015 The American Society of Human Genetics. The 22q11.2 deletion syndrome is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect, mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects, 603 with CHDs and 346 with normal cardiac anatomy. Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without. In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs. The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis, indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.